VENUS REMEDIES
Back to Balance Sheet
|
VENUS REMEDIES Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹20 Cr | ₹38 Cr | ₹30 Cr | ₹40 Cr | ₹11 Cr |
What is the latest Contingent Liabilities ratio of VENUS REMEDIES ?
| Year | Contingent Liabilities |
|---|---|
| Mar2026 | ₹20 Cr |
| Mar2025 | ₹38 Cr |
| Mar2024 | ₹30 Cr |
| Mar2023 | ₹40 Cr |
| Mar2022 | ₹11 Cr |
How is Contingent Liabilities of VENUS REMEDIES Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹20 Cr | -48.00 | |
| Mar2025 | ₹38 Cr | 25.48 | |
| Mar2024 | ₹30 Cr | -23.13 | |
| Mar2023 | ₹40 Cr | 272.42 | |
| Mar2022 | ₹11 Cr | - | |
Compare Contingent Liabilities of peers of VENUS REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VENUS REMEDIES | ₹2,240.0 Cr | 4.4% | 8% | 264.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹455,826.0 Cr | -1.6% | -2.5% | 21.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹247,019.0 Cr | 1.5% | 12.8% | 48.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹186,875.0 Cr | -0.9% | -0.8% | 35.3% | Stock Analytics | |
| CIPLA | ₹112,773.0 Cr | -1.6% | -5.2% | -11.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,570.9 Cr | -2.2% | -2.3% | -8.2% | Stock Analytics | |
VENUS REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VENUS REMEDIES | 4.4% |
8% |
264.6% |
| SENSEX | -1.1% |
-3.6% |
-5.3% |
You may also like the below Video Courses